epigallocatechin gallate has been researched along with polydatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Cao, Z; Ding, G; Ding, Y; Ke, Z; Liu, H; Su, Z; Wang, Z; Xiao, W; Zhang, X | 1 |
| Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
3 other study(ies) available for epigallocatechin gallate and polydatin
| Article | Year |
|---|---|
Discovery of a potent angiotensin converting enzyme inhibitor via virtual screening.
Topics: Angiotensin-Converting Enzyme Inhibitors; Binding Sites; Catechin; Chalcones; Drug Evaluation, Preclinical; Humans; Molecular Docking Simulation; Peptidyl-Dipeptidase A; Protein Binding; Protein Structure, Tertiary; Pyrrolizidine Alkaloids | 2017 |
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |